Key facts
- It has raised $13.8M; the latest was Later Stage VC ($7.0M) in Jun 2025.
- Notable investors include US National Science Foundation, Gaingels, StartX (US), United States Department of Agriculture, Ulu Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Empo Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Empo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Empo Health
Developer of an in-home imaging scale and digital health platform designed to monitor for early signs of diabetic foot conditions and prevent amputations. The company makes full-color imaging scales and does foot monitoring, enabling patients and clinicians to access reliable visual data outside the clinic, and integrates it with the standard of care.
- Sector
- Healthcare
- HQ
- San Bruno, CA, United States
- Founded
- 2020
- Employees
- 28
- Website
- empohealth.com/
- Ownership
- Privately Held (backing)
Empo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Empo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Empo Health in its N-PORT filings yet. We sweep new filings monthly.